Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
| Ticker | Company | Sub-Theme | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $300.7b | $190.00 | -1.2% | 2.4M |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $178.3b | $467.89 | +0.3% | 2.7M |
 DHR | Danaher Corporation | Precision Medicine Platforms | $130.1b | $177.65 | -0.5% | 6.4M |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $112.6b | $430.24 | -1.1% | 1.1M |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $79.2b | $751.48 | -1.9% | 809.5K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $41.9b | $305.65 | -2.6% | 825.6K |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $33.0b | $135.16 | -6.0% | 2.5M |
 WAT | Waters Corp | Precision Medicine Platforms | $28.8b | $308.88 | -0.7% | 869.8K |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $26.5b | $204.03 | +1.4% | 1.0M |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $21.7b | $263.80 | -0.4% | 494.4K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $18.5b | $127.94 | +2.0% | 886.6K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.4b | $73.28 | +2.2% | 4.1M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $12.0b | $73.24 | -1.1% | 1.8M |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $11.3b | $88.89 | +1.2% | 1.2M |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $10.5b | $53.16 | -1.5% | 1.1M |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $9.5b | $86.77 | -0.4% | 1.2M |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $8.1b | $54.19 | +3.8% | 2.0M |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.1b | $38.41 | +1.2% | 1.2M |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $8.1b | $73.93 | -0.6% | 1.6M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $7.7b | $344.83 | +4.6% | 345.9K |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $104.50 | -3.3% | 993.5K |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $52.20 | +1.5% | 3.8M |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $7.2b | $272.51 | +1.7% | 264.1K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $6.5b | $84.92 | -2.6% | 393.7K |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.8b | $20.21 | +2.1% | 830.4K |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $4.8b | $84.35 | +1.8% | 476.5K |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.2% | 5.3M |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $4.3b | $48.79 | -11.6% | 3.9M |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $3.2b | $85.00 | +1.3% | 234.7K |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $18.28 | -3.3% | 1.2M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $30.73 | +0.1% | 649.1K |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $2.7b | $60.95 | +3.6% | 945.4K |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $2.5b | $22.09 | +3.1% | 1.6M |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $2.4b | $34.34 | +3.6% | 635.4K |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $27.11 | -10.1% | 4.7M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $20.27 | -0.7% | 2.1M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $2.0b | $14.15 | +2.4% | 876.1K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $1.7b | $68.46 | +3.4% | 457.2K |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $1.6b | $35.61 | +3.5% | 565.7K |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.4b | $25.82 | -0.7% | 504.0K |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.4b | $16.00 | +0.8% | 9.0M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.2b | $7.18 | -1.8% | 2.8M |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $6.39 | -0.2% | 1.9M |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $4.13 | +4.2% | 3.5M |
 PCRX | Pacira BioSciences, Inc. Common Stock | Gene Therapy & Gene Editing | $0.9b | $24.51 | -3.4% | 525.9K |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $0.9b | $8.29 | +4.8% | 1.3M |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $0.9b | $25.92 | +3.2% | 825.1K |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $0.9b | $18.06 | +3.0% | 1.0M |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $0.9b | $21.36 | -1.7% | 362.4K |
 CDNA | CareDx, Inc. | Precision Medicine PlatformsGenetic Testing & Diagnostics | $0.8b | $21.23 | +5.8% | 570.7K |